Browse the detailed record of transactions filed by Downing Philip A, Vice-Président Senior. Director active across 1 companies, notably Inotiv, Inc.. In total, 7 reports have been published. Total volume traded: €509k. The latest transaction was filed on 22 February 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Philip A. Downing is the Senior Vice President of Preclinical Services at Inotiv, Inc. He oversees the operations of the company's preclinical services, ensuring the quality and compliance of research. His expertise is essential for the development of new treatments.